From a long-term perspective, $MOH (+4,03%) continues to be an attractive roll-up strategy that can benefit from adding smaller single-state health insurers to its platform.
Molina's attractive valuation, cost control strategies, and growth outlook make it a potential buy for investors looking for long-term rewards.
$MOH (+4,03%) stock is down nearly -25% from YTD highs, but Q2 results show stabilizing medical expense ratios, assuaging investor fears.
Its attractive valuation, cost control strategies, and growth outlook make it a potential buy for investors looking for long-term upside. Anyone bullish on this stock?🤔
$MOH (+4,03%) I know that maybe this company is little known but I want to tell you to prepare a cup of tea and go and see its balance sheet, it's worth it.
I have been thinking about which stocks I could use to beat the S&P500 index.
After a lot of research, I have now decided on 20 American shares, which I will save 100 euros/month each in savings plans from 01.04.2024. As I didn't want any overlaps/duplications with my ETFs (World and Consumer Staples), I chose companies from the second tier. Perhaps one or two of the stocks will also be of interest to you 😉
